CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress

1. Shah, M.
2. Grothey, A.
3. Tebbutt, N.
4. Xu, R.
5. Yoshino, T.
6. Cervantes, A.
7. Tabernero, J.
8. Taieb, J.
9. Falcone, A.
10. Xu, B.
11. Fontaine, M.
12. Borodyansky, L.
13. Van Cutsem, E.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDY151.296 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus